DRIVE-UFNCT07637110
Dry Weight Reduction Intervention Via Extra Ultrafiltration
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 4 more changesShow less
- Eligibility criteria expanded, about 22 words
- Start date changed from estimate of Jun 2026 to Sep 10, 2026
- Site details revised
- Study description expanded, about 2 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
24-hour continuous ambulatory blood pressure
Timeframe: Measurement performed at baseline compared to measurement performed at 24 weeks.
Symptoms of congestion.
Timeframe: Questionnaire taken at Baseline compared the the questionnaire taken at 24 weeks.
Arms and interventions
Ultrafiltration treatments for up to 4 weeksActive comparator
Two ultrafiltration treatments per week for up to 4 weeks; pharmacist guided tapering of blood pressure medications for up to 4 weeks; and regular thrice weekly hemodialysis treatments.
Ultrafiltration treatments for up to 8 weeksActive comparator
Two ultrafiltration treatments per week for up to 8 weeks; pharmacist guided tapering of blood pressure medications for up to 8 weeks; and regular thrice weekly hemodialysis treatments.
Control armNo intervention
Regular thrice weekly hemodialysis treatments.
Procedures: Ultrafiltration
Sites
1 site in 1 country
- Northwest Kidney CentersSeattle, Washington, United States